mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-08 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |